Maria Berkman, MD, MBA is a Partner at Vensana Capital. Prior to Vensana, Maria was the Head of MedTech at Broadview Ventures and Managing Director of Longview Ventures – affiliate funds dedicated to cardiovascular disease and stroke. Maria currently serves on the boards of Alleviant Medical and Vensana Innovation and previously served as Chair of AtaCor Medical (partnered with Abbott), and on the boards of Vectorious (acquired), Apama (acquired), CardiAQ (acquired), Remedy Therapeutics (acquired), Capricor (IPO) and Lyra Therapeutics (IPO). Prior to her venture career, Maria was a management consultant with Monitor Group and trained at Mass General Brigham’s Newton Wellesley Hospital.  Outside her venture career, Maria serves on the Board of the Boston Museum of Science and as a member of the Acquisitions Circle at the Institute of Contemporary Art / Boston.